Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biomerica ( (BMRA) ) just unveiled an announcement.
On October 7, 2025, Biomerica, Inc. announced the appointment of Gary Huff to its Board of Directors, increasing the board size from five to six members. Huff, a seasoned leader in the healthcare industry with over 35 years of experience, will also serve on several key committees. His extensive background in laboratory management and strategic advisory services is expected to contribute significantly to Biomerica’s growth and market expansion. Additionally, Dr. Jane Emerson, a long-serving board member, will not stand for re-election at the 2025 Annual Meeting, leading to a reduction in the board size back to five members.
The most recent analyst rating on (BMRA) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Biomerica stock, see the BMRA Stock Forecast page.
Spark’s Take on BMRA Stock
According to Spark, TipRanks’ AI Analyst, BMRA is a Underperform.
Biomerica’s overall stock score is primarily impacted by its poor financial performance and valuation. The company’s financial struggles, including declining revenues and negative profitability, are significant concerns. Technical analysis also indicates bearish momentum. While the appointment of a new board member is a positive step, it does not significantly offset the financial and technical challenges.
To see Spark’s full report on BMRA stock, click here.
More about Biomerica
Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced diagnostic and therapeutic products. The company’s products are designed for use at the point of care and in hospital/clinical laboratories, primarily focusing on gastrointestinal and inflammatory diseases. Biomerica aims to enhance health and well-being while reducing healthcare costs.
Average Trading Volume: 802,486
Technical Sentiment Signal: Sell
Current Market Cap: $8.41M
See more data about BMRA stock on TipRanks’ Stock Analysis page.